awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26750891-AAF73370-70E8-4760-B424-32B8353BAEC6
Q26750891-AAF73370-70E8-4760-B424-32B8353BAEC6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750891-AAF73370-70E8-4760-B424-32B8353BAEC6
Systemic Immunotherapy for the Treatment of Brain Metastases
P2860
Q26750891-AAF73370-70E8-4760-B424-32B8353BAEC6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750891-AAF73370-70E8-4760-B424-32B8353BAEC6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1906758f7365aff772c4192cd731a684ef35e7d2
P2860
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.